Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy.

Guérin MV, Ruggiu M, Feldmann LC, Corre B, Ombredanne P, Iannascoli B, Garcia Z, Lemaître F, Macdonald L, Guermonprez P, Grandjean CL, Bruhns P, Bousso P

Open source

DOI: 10.1136/jitc-2025-014665
Published: 2026 Jun 12
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-014665,
  title = {Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy.},
  author = {Guérin MV and Ruggiu M and Feldmann LC and Corre B and Ombredanne P and Iannascoli B and Garcia Z and Lemaître F and Macdonald L and Guermonprez P and Grandjean CL and Bruhns P and Bousso P},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-014665},
  url = {https://doi.org/10.1136/jitc-2025-014665}
}

RIS

TY  - JOUR
TI  - Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy.
AU  - Guérin MV
AU  - Ruggiu M
AU  - Feldmann LC
AU  - Corre B
AU  - Ombredanne P
AU  - Iannascoli B
AU  - Garcia Z
AU  - Lemaître F
AU  - Macdonald L
AU  - Guermonprez P
AU  - Grandjean CL
AU  - Bruhns P
AU  - Bousso P
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-014665
UR  - https://doi.org/10.1136/jitc-2025-014665
ER  -

APA

MV, G., M, R., LC, F., B, C., P, O., B, I., Z, G., F, L., L, M., P, G., CL, G., P, B., & P, B. (2026). Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-014665

Source records

pubmed · retrieved 2026-09-26T09:38:25.920Z
europe-pmc · retrieved 2026-09-26T09:38:25.927Z